CHAPTER 3.1 108 Supplementary table 2 (continued). Baseline characteristics of total registry population, RCT-eligible and RCT-ineligible stratified by sex Total Registries RCT-Eligible RCT-non-eligible Females Males Females Males Females Males Medications *ACEI or ARB 84.3% (12299) 88.4% (28578) 100.0% (8294) 100.0% (17810) 63.7% (4005) 74.2% (10768) Antiplatelet 47.0% (6860) 47.2% (15256) 48.2% (3995) 46.8% (8334) 45.5% (2865) 47.7% (6922) Anticoagulant 37.5% (5475) 44.9% (14518) 40.7% (3375) 48.1% (8572) 33.4% (2100) 41.0% (5946) MRA 36.5% (5317) 36.6% (11836) 38.4% (3187) 39.8% (7087) 33.9% (2130) 32.7% (4749) *Betablocker 87.8% (12799) 88.8% (28697) 100.0% (8294) 100.0% (17810) 71.6% (4505) 75.0% (10887) Digitalis glycoside 16.5% (2412) 15.6% (5037) 17.1% (1422) 17.0% (3025) 15.7% (990) 13.9% (2012) Diuretic 81.5% (11884) 77.9% (25192) 81.9% (6792) 78.1% (13905) 81.0% (5092) 77.7% (11287) Outcomes All-cause mortality 20.1% (2473) 14.0% (1005) 28.6% (1468) 16.8% (4688) 10.7% (1671) 24.6% (3017) CV-cause mortality 14.6% (1799) 10.6% (761) 20.2% (1038) 12.0% (3345) 8.1% (1267) 17.0% (2078) First HF Hospitalization 23.4% (2874) 23.2% (1660) 23.7% (1214) 25.0% (6982) 24.8% (3885) 25.3% (3097) *Indicates an exclusion or inclusion criteria to determine RCT-eligible/ineligible population
RkJQdWJsaXNoZXIy MjY0ODMw